X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CIPLA UNICHEM LAB/
CIPLA
 
P/E (TTM) x -273.1 37.5 - View Chart
P/BV x 2.0 3.9 52.2% View Chart
Dividend Yield % 1.3 0.3 381.6%  

Financials

 UNICHEM LAB   CIPLA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
CIPLA
Mar-17
UNICHEM LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs320622 51.4%   
Low Rs221458 48.2%   
Sales per share (Unadj.) Rs167.2181.9 91.9%  
Earnings per share (Unadj.) Rs12.012.9 92.9%  
Cash flow per share (Unadj.) Rs16.929.3 57.8%  
Dividends per share (Unadj.) Rs3.002.00 150.0%  
Dividend yield (eoy) %1.10.4 299.6%  
Book value per share (Unadj.) Rs117.0155.7 75.2%  
Shares outstanding (eoy) m90.88804.51 11.3%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.63.0 54.5%   
Avg P/E ratio x22.642.0 53.9%  
P/CF ratio (eoy) x16.018.4 86.7%  
Price / Book Value ratio x2.33.5 66.6%  
Dividend payout %25.115.5 161.4%   
Avg Mkt Cap Rs m24,578434,516 5.7%   
No. of employees `0005.223.0 22.5%   
Total wages/salary Rs m2,48726,338 9.4%   
Avg. sales/employee Rs Th2,928.36,349.1 46.1%   
Avg. wages/employee Rs Th479.41,143.0 41.9%   
Avg. net profit/employee Rs Th209.4449.3 46.6%   
INCOME DATA
Net Sales Rs m15,195146,302 10.4%  
Other income Rs m1102,287 4.8%   
Total revenues Rs m15,305148,589 10.3%   
Gross profit Rs m1,78824,758 7.2%  
Depreciation Rs m45213,229 3.4%   
Interest Rs m341,594 2.1%   
Profit before tax Rs m1,41312,222 11.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3261,798 18.1%   
Profit after tax Rs m1,08710,354 10.5%  
Gross profit margin %11.816.9 69.5%  
Effective tax rate %23.114.7 156.8%   
Net profit margin %7.27.1 101.1%  
BALANCE SHEET DATA
Current assets Rs m6,42687,370 7.4%   
Current liabilities Rs m3,91733,081 11.8%   
Net working cap to sales %16.537.1 44.5%  
Current ratio x1.62.6 62.1%  
Inventory Days Days6887 77.8%  
Debtors Days Days7762 123.6%  
Net fixed assets Rs m7,410111,567 6.6%   
Share capital Rs m1821,609 11.3%   
"Free" reserves Rs m10,454123,645 8.5%   
Net worth Rs m10,636125,254 8.5%   
Long term debt Rs m436,454 0.0%   
Total assets Rs m15,258209,532 7.3%  
Interest coverage x42.98.7 495.1%   
Debt to equity ratio x00.3 0.1%  
Sales to assets ratio x1.00.7 142.6%   
Return on assets %7.35.7 128.8%  
Return on equity %10.28.3 123.6%  
Return on capital %13.68.5 159.9%  
Exports to sales %24.134.2 70.5%   
Imports to sales %4.98.3 59.3%   
Exports (fob) Rs m3,66650,050 7.3%   
Imports (cif) Rs m75212,203 6.2%   
Fx inflow Rs m5,29851,066 10.4%   
Fx outflow Rs m017,678 0.0%   
Net fx Rs m5,29833,388 15.9%   
CASH FLOW
From Operations Rs m68323,824 2.9%  
From Investments Rs m-1,316-13,127 10.0%  
From Financial Activity Rs m592-13,239 -4.5%  
Net Cashflow Rs m-40-2,478 1.6%  

Share Holding

Indian Promoters % 50.1 16.0 313.1%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 15.1 12.2 123.8%  
FIIs % 3.0 23.7 12.7%  
ADR/GDR % 0.0 1.1 -  
Free float % 31.7 26.2 121.0%  
Shareholders   20,176 161,166 12.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   DR. DATSONS LABS  DISHMAN PHARMA  TTK HEALTHCARE  NATCO PHARMA  BIOCON LTD  

Compare UNICHEM LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Metal & Realty Stocks Fall(Closing)

Indian share markets ended lower today amid weak global cues. At the closing bell, the BSE Sensex finished lower by 262 points.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

CIPLA Announces Quarterly Results (4QFY18); Net Profit Down 347.8%

May 24, 2018 | Updated on May 24, 2018

For the quarter ended March 2018, CIPLA has posted a net profit of Rs 2 bn (down 347.8% YoY). Sales on the other hand came in at Rs 37 bn (up 3.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Cipla: Extraordinary Income Boosts Net Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

Proceeds from the sale of the South African animal business bolstered Cipla's net profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 19, 2018 03:37 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS